Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ALT
#3034
Altimmune, Inc. Common Stock
3.2
9
USD
+1.86%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.86%
Monthly Change
-8.61%
6 month change
-17.34%
Year Change
-28.17%
Previous Close
3.2
3
Open
3.2
9
Bid
Ask
Low
3.2
9
High
3.2
9
Volume
77
Markets
US Stock Market
Healthcare
ALT
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
37.15 M
43.22 M
49.28 M
70.9 M
77.01 M
130.07 M
—
Valuation ratios
Enterprise value
306.79 M
208.61 M
664.84 M
610.7 M
518.34 M
461.48 M
1.34 B
Price to earnings ratio
—
-3.9
-8.64
-6.34
-5.38
-3.61
-14.38
Price to sales ratio
—
85.74
-10.79 K
1 314.92
25.6 K
7 757.46
55.05 K
Price to cash flow ratio
—
-4.83
-11.72
-7.39
-6.41
-4.71
-17.14
Price to book ratio
—
1.9
3.96
2.89
4.14
1.41
3.08
Enterprise value to EBITDA ratio
-5.56
-2.13
-7.56
-6.24
-4.85
-4.42
-13.16
Profitability ratios
Return on assets %
-0.2
-0.44
-0.41
-0.42
-0.68
-0.31
-0.43
Return on equity %
-0.22
-0.49
-0.46
-0.46
-0.77
-0.39
-0.5
Return on invested capital %
-1 240.11
-1 610.96
-1 362.31
-2 511.47
—
-4 444.59
-4 768.99
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-669.5
-2 197.42
129.03 K
-22.52 K
-515.86 K
-230.46 K
-1.42 M
EBITDA margin %
-665.86
-2 184.92
128.29 K
-22.99 K
-533.92 K
-234.73 K
-1.45 M
Net margin %
-599.2
-2 201.43
124.58 K
-20.76 K
-475.29 K
-214.86 K
-1.32 M
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
19.16
11.17
11.31
17.26
13.11
18.55
72.02
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.05
0.02
-0
0
0
0
0
Solvency ratios
Debt to assets ratio
0.01
0.01
0.03
—
—
0.13
—
Debt to equity ratio
0.02
0.02
0.03
—
—
0.16
—
Long term debt to total assets ratio
0.01
0.01
0.02
—
—
0.12
—
Long term debt to total equity ratio
0.01
0.01
0.02
—
—
0.15
—
Per share metrics
Operating cash flow per share
—
-1.9
-1.33
-1.42
-1.12
-0.77
-0.81
EBIT per share
—
-2.35
-1.87
-1.8
-1.45
-1.07
-1.13
EBITDA per share
—
-2.33
-1.86
-1.84
-1.5
-1.09
-1.15
Total debt per share
—
0.07
0.12
—
—
0.41
—
Cash per share
—
4.61
3.94
3.72
1.86
3.1
9.69
Net current asset value per share
—
4.94
4.11
3.94
1.93
3.16
9.95
Tangible book value per share
—
4.52
3.68
3.65
1.74
2.55
8.49
Working capital per share
—
4.5
3.75
3.71
1.79
2.99
9.39
Book value per share
—
4.82
3.95
3.65
1.74
2.55
8.49
News
ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms
Altimmune Stock: Neutral Outlook With Big 2026 Catalysts
ALT Pemvidutide Explained: What Makes It Different in MASH
H.C. Wainwright raises Altimmune stock price target on MASH focus
Altimmune at Barclays Conference: Advancing Pemvidutide’s Potential
Altimmune at Leerink Conference: Strategic Advances in MASH Treatment
Altimmune CEO Durso buys $70,790 in shares
Altimmune CFO Weaver buys $17,700 in shares
Altimmune, Inc. (ALT) Q4 2025 Earnings Call Transcript
William Blair reiterates Altimmune stock rating on trial data
Altimmune earnings missed by $0.02, revenue fell short of estimates
Altimmune stock edges down on fourth quarter earnings miss